Approval · Notice of Compliance 11459 · 2010
BERINERT: Notice of Compliance 11459
Issued May 31, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11459
- Date
- May 31, 2010
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Serine protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BERINERT | 02352575 | Marketed |
Medicinal ingredients
- C1 ESTERASE INHIBITOR (HUMAN) 500 UNIT per VIAL